Although liquid biopsy for ALK-rearranged NSCLC is still under investigation, it is expected to be a useful tool for detecting genetic mutations with false-negative results by tissue biopsy and investigating resistance mechanisms. Here, ALK is linked to non-small cell lung carcinoma.